Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes. (November 2022) - Loveday, C.; Garrett, A.; Law, P.; Hanks, S.; Poyastro-Pearson, E.; Eccles, D.; Evans, G.; Snape, K.; Hanson, H.; Houlston, R.; Turnbull, C.; ,